These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 23904197)

  • 1. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
    Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
    Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of interneuron populations and correlation with amyloid-β deposition in the olfactory cortex of an AβPP/PS1 transgenic mouse model of Alzheimer's disease.
    Saiz-Sanchez D; Ubeda-Bañon I; De la Rosa-Prieto C; Martinez-Marcos A
    J Alzheimers Dis; 2012; 31(1):113-29. PubMed ID: 22543847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
    Baglietto-Vargas D; Moreno-Gonzalez I; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
    J Alzheimers Dis; 2010; 21(1):119-32. PubMed ID: 20413859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer's disease.
    Saiz-Sanchez D; De la Rosa-Prieto C; Ubeda-Banon I; Martinez-Marcos A
    Brain Struct Funct; 2015 Jul; 220(4):2011-25. PubMed ID: 24748561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β deposition and olfactory dysfunction in an Alzheimer's disease model.
    Wu N; Rao X; Gao Y; Wang J; Xu F
    J Alzheimers Dis; 2013; 37(4):699-712. PubMed ID: 23948910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Hippocampal Calretinin and Parvalbumin Interneurons in the 5XFAD Mouse Model of Alzheimer's Disease.
    Giesers NK; Wirths O
    ASN Neuro; 2020; 12():1759091420925356. PubMed ID: 32423230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.
    Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX
    Neuroscience; 2012 Jul; 215():160-73. PubMed ID: 22542680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb.
    Rusznák Z; Kim WS; Hsiao JH; Halliday GM; Paxinos G; Fu Y
    J Alzheimers Dis; 2016; 49(2):443-57. PubMed ID: 26484907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and expression of Pen-2 in the central nervous system of APP/PS1 double transgenic mice.
    Chu Y; Peng X; Long Z; Wang K; Luo S; Sharma A; He G
    Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):258-66. PubMed ID: 25736404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease.
    Takahashi H; Brasnjevic I; Rutten BP; Van Der Kolk N; Perl DP; Bouras C; Steinbusch HW; Schmitz C; Hof PR; Dickstein DL
    Brain Struct Funct; 2010 Mar; 214(2-3):145-60. PubMed ID: 20213270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid ameliorates olfactory dysfunction in APP/PS1 transgenic mice of Alzheimer's disease: Ameliorations from the olfactory epithelium to the olfactory bulb.
    Yao ZG; Jing HY; Wang DM; Lv BB; Li JM; Liu FF; Fan H; Sun XC; Qin YJ; Zhao MQ
    Pharmacol Biochem Behav; 2016 May; 144():53-9. PubMed ID: 26948859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denervation of the olfactory bulb leads to decreased Aβ plaque load in a transgenic mouse model of Alzheimer' s disease.
    Bibari O; Lee S; Dickson TC; Mitew S; Vickers JC; Chuah MI
    Curr Alzheimer Res; 2013 Sep; 10(7):688-96. PubMed ID: 23905998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging, but not tau pathology, impacts olfactory performances and somatostatin systems in THY-Tau22 mice.
    Martel G; Simon A; Nocera S; Kalainathan S; Pidoux L; Blum D; Leclère-Turbant S; Diaz J; Geny D; Moyse E; Videau C; Buée L; Epelbaum J; Viollet C
    Neurobiol Aging; 2015 Feb; 36(2):1013-28. PubMed ID: 25433460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interneurons in the human olfactory system in Alzheimer's disease.
    Saiz-Sanchez D; Flores-Cuadrado A; Ubeda-Bañon I; de la Rosa-Prieto C; Martinez-Marcos A
    Exp Neurol; 2016 Feb; 276():13-21. PubMed ID: 26616239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease.
    Saiz-Sanchez D; Ubeda-Bañon I; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Insausti R; Martinez-Marcos A
    Exp Neurol; 2010 Jun; 223(2):347-50. PubMed ID: 19559700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulnerability of calbindin, calretinin and parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis.
    Verdaguer E; Brox S; Petrov D; Olloquequi J; Romero R; de Lemos ML; Camins A; Auladell C
    Exp Gerontol; 2015 Sep; 69():176-88. PubMed ID: 26099796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.